Skip to Main Content

Advertisement

Skip Nav Destination

NYU Langone’s Center for Blood Cancers Appoints Faith E. Davies as Inaugural Director

March 31, 2022

April 2022

Faith E. Davies, MD

Faith E. Davies, MD

Faith E. Davies, MD, has been appointed as the inaugural director of the Center for Blood Cancers at NYU Langone Health’s Perlmutter Cancer Center. Dr. Davies is the director of the clinical myeloma program at Perlmutter Cancer Center and is a professor in the Department of Medicine at NYU Grossman School of Medicine. Previously, she was the medical director of the Myeloma Institute at University of Arkansas for Medical Sciences.

“We are delighted that Dr. Davies will be leading the Center for Blood Cancers,” said Michael L. Grossbard, MD, professor in the Department of Medicine at NYU Grossman School of Medicine and section chief of hematology at Perlmutter Cancer Center. “Her work has been fundamental to revealing the importance of achieving complete remission in myeloma therapy, and under her leadership, the center is poised to extend treatment advances for all blood cancers.”

She and her colleagues are building a clinical trial portfolio concentrating on new immunotherapy approaches, investigating new immunomodulatory drugs, bispecific antibodies, and chimeric antigen receptor (CAR) T cell approaches. In collaboration with Gareth J. Morgan, MD, PhD, professor in the Department of Medicine at NYU Grossman School of Medicine and director of multiple myeloma research at Perlmutter Cancer Center, Dr. Davies is investigating the impact of both tumor genomics and the immune microenvironment on the outcome of these immune strategies.

Sources: NYU Langone Health NewsHub, January 24, 2022.

Advertisement

Connect with us:

CURRENT ISSUE
April 2024

Advertisement

Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement